InvestorsHub Logo

DewDiligence

11/07/17 6:40 PM

#28 RE: DewDiligence #23

TCON 3Q17 results:

https://finance.yahoo.com/news/tracon-pharmaceuticals-reports-third-quarter-210500262.html

9/30/17 cash was $35.9M, $3.9M higher than the 6/30/17 balance, due to the $7M milestone received from Santen during July.

Excluding the milestone payment, 3Q17 operating cash burn was $3.1M.